Photorefractive Keratectomy for Lazy Eye
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether Photorefractive Keratectomy (PRK), a laser eye surgery, can improve vision in children with "lazy eye" (amblyopia) who haven't responded to standard treatments. PRK already corrects vision problems like nearsightedness and farsightedness in adults, so researchers aim to determine if it can assist children with severe vision differences between their eyes or similar severe issues in both eyes. Children aged 2 to 17 with such vision problems, who haven't improved after six months of regular treatment, might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to explore a new application of an existing treatment, potentially benefiting children who have not found success with other options.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that photorefractive keratectomy is safe for children with amblyopia?
Research has shown that photorefractive keratectomy (PRK) is a safe procedure for treating vision problems. In children with severe vision issues, such as anisometropic amblyopia (where one eye is weaker than the other), PRK significantly improves vision over time. Studies indicate that it leads to long-lasting vision improvement and enhances the eye's ability to focus light.
PRK has been used in adults for over 35 years, providing extensive information about its safety. In adults with amblyopia ("lazy eye"), PRK has improved vision and may even enhance binocular vision. Although some short-term side effects, like discomfort or changes in vision, can occur, these typically resolve as the eye heals.
Overall, PRK is well-tolerated and has a strong safety record in both adults and children, making it a promising option for children who haven't had success with other treatments for amblyopia.12345Why are researchers excited about this trial?
Photorefractive Keratectomy (PRK) is unique because it offers a surgical approach to treating lazy eye, unlike traditional methods like patching or atropine drops that focus on strengthening the weaker eye. PRK reshapes the cornea in the affected eye, potentially improving vision directly through physical change rather than just compensatory measures. Researchers are excited about PRK because it may provide a more permanent solution by addressing the structural issues of the eye, offering hope for lasting visual correction.
What evidence suggests that photorefractive keratectomy might be an effective treatment for amblyopia?
Research has shown that photorefractive keratectomy (PRK) effectively treats vision issues like nearsightedness, farsightedness, and astigmatism in adults for over 35 years. Studies indicate that about 70% of PRK patients achieve 20/20 vision, and 92% experience significantly better vision after surgery. Although this trial focuses on children, previous research has demonstrated that refractive surgery can be safe and effective for kids with unequal vision in their eyes. PRK has also shown promise in improving vision in adults with lazy eye. These findings suggest that PRK could effectively treat lazy eye in children who do not respond to standard treatments.678910
Who Is on the Research Team?
Evelyn Paysse, MD
Principal Investigator
Baylor College of Medicine
Are You a Good Fit for This Trial?
This trial is for children aged 2 to 17 with severe anisometropia or isoametropia and lazy eye (amblyopia) who haven't improved after at least 6 months of standard treatment. They must have a significant difference in vision between eyes or high near-sightedness, farsightedness, or astigmatism. Kids with certain corneal issues, collagen disorders, previous herpes infections in the eye, or very thin corneas can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo photorefractive keratectomy (PRK) in the affected eye(s) using previously derived formulas
Follow-up
Participants are monitored for visual acuity, refractive error stability, and corneal health
What Are the Treatments Tested in This Trial?
Interventions
- Photorefractive Keratectomy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor College of Medicine
Lead Sponsor